These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 33111402)

  • 21. The Impact of Type 2 Diabetes in Parkinson's Disease.
    Athauda D; Evans J; Wernick A; Virdi G; Choi ML; Lawton M; Vijiaratnam N; Girges C; Ben-Shlomo Y; Ismail K; Morris H; Grosset D; Foltynie T; Gandhi S
    Mov Disord; 2022 Aug; 37(8):1612-1623. PubMed ID: 35699244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers.
    Sugier PE; Lucotte EA; Domenighetti C; Law MH; Iles MM; Brown K; Amos C; McKay JD; Hung RJ; Karimi M; Bacq-Daian D; Boland-Augé A; Olaso R; Deleuze JF; Lesueur F; Ostroumova E; Kesminiene A; de Vathaire F; Guénel P; ; Sreelatha AAK; Schulte C; Grover S; May P; Bobbili DR; Radivojkov-Blagojevic M; Lichtner P; Singleton AB; Hernandez DG; Edsall C; Mellick GD; Zimprich A; Pirker W; Rogaeva E; Lang AE; Koks S; Taba P; Lesage S; Brice A; Corvol JC; Chartier-Harlin MC; Mutez E; Brockmann K; Deutschländer AB; Hadjigeorgiou GM; Dardiotis E; Stefanis L; Simitsi AM; Valente EM; Petrucci S; Straniero L; Zecchinelli A; Pezzoli G; Brighina L; Ferrarese C; Annesi G; Quattrone A; Gagliardi M; Matsuo H; Nakayama A; Hattori N; Nishioka K; Chung SJ; Kim YJ; Kolber P; van de Warrenburg BPC; Bloem BR; Aasly J; Toft M; Pihlstrøm L; Guedes LC; Ferreira JJ; Bardien S; Carr J; Tolosa E; Ezquerra M; Pastor P; Diez-Fairen M; Wirdefeldt K; Pedersen N; Ran C; Belin AC; Puschmann A; Rödström EY; Clarke CE; Morrison KE; Tan M; Krainc D; Burbulla LF; Farrer MJ; Kruger R; Gasser T; Sharma M; ; Truong T; Elbaz A
    Mov Disord; 2023 Apr; 38(4):604-615. PubMed ID: 36788297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-reference genome transposable elements (TEs) have a significant impact on the progression of the Parkinson's disease.
    Kõks S; Pfaff AL; Singleton LM; Bubb VJ; Quinn JP
    Exp Biol Med (Maywood); 2022 Sep; 247(18):1680-1690. PubMed ID: 36000172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource.
    Iwaki H; Leonard HL; Makarious MB; Bookman M; Landin B; Vismer D; Casey B; Gibbs JR; Hernandez DG; Blauwendraat C; Vitale D; Song Y; Kumar D; Dalgard CL; Sadeghi M; Dong X; Misquitta L; Scholz SW; Scherzer CR; Nalls MA; Biswas S; Singleton AB; ; ;
    Mov Disord; 2021 Aug; 36(8):1795-1804. PubMed ID: 33960523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain and Systemic Inflammation in De Novo Parkinson's Disease.
    Yacoubian TA; Fang YD; Gerstenecker A; Amara A; Stover N; Ruffrage L; Collette C; Kennedy R; Zhang Y; Hong H; Qin H; McConathy J; Benveniste EN; Standaert DG
    Mov Disord; 2023 May; 38(5):743-754. PubMed ID: 36853618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease.
    Liu G; Peng J; Liao Z; Locascio JJ; Corvol JC; Zhu F; Dong X; Maple-Grødem J; Campbell MC; Elbaz A; Lesage S; Brice A; Mangone G; Growdon JH; Hung AY; Schwarzschild MA; Hayes MT; Wills AM; Herrington TM; Ravina B; Shoulson I; Taba P; Kõks S; Beach TG; Cormier-Dequaire F; Alves G; Tysnes OB; Perlmutter JS; Heutink P; Amr SS; van Hilten JJ; Kasten M; Mollenhauer B; Trenkwalder C; Klein C; Barker RA; Williams-Gray CH; Marinus J; ; Scherzer CR
    Nat Genet; 2021 Jun; 53(6):787-793. PubMed ID: 33958783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide variant by serum urate interaction in Parkinson's disease.
    Nazeri A; Roostaei T; Sadaghiani S; Chakravarty MM; Eberly S; Lang AE; Voineskos AN
    Ann Neurol; 2015 Nov; 78(5):731-41. PubMed ID: 26284320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptomic analysis reveals associations of blood-based A-to-I editing with Parkinson's disease.
    Li W; Wu H; Li J; Wang Z; Cai M; Liu X; Liu G
    J Neurol; 2024 Feb; 271(2):976-985. PubMed ID: 37902879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.
    Gaare JJ; Nido GS; Sztromwasser P; Knappskog PM; Dahl O; Lund-Johansen M; Maple-Grødem J; Alves G; Tysnes OB; Johansson S; Haugarvoll K; Tzoulis C
    Mov Disord; 2018 Oct; 33(10):1591-1600. PubMed ID: 30256453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential Protective Link Between Type I Diabetes and Parkinson's Disease Risk and Progression.
    Senkevich K; Alipour P; Chernyavskaya E; Yu E; Noyce AJ; Gan-Or Z
    Mov Disord; 2023 Jul; 38(7):1350-1355. PubMed ID: 37148456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study.
    Foo JN; Chew EGY; Chung SJ; Peng R; Blauwendraat C; Nalls MA; Mok KY; Satake W; Toda T; Chao Y; Tan LCS; Tandiono M; Lian MM; Ng EY; Prakash KM; Au WL; Meah WY; Mok SQ; Annuar AA; Chan AYY; Chen L; Chen Y; Jeon BS; Jiang L; Lim JL; Lin JJ; Liu C; Mao C; Mok V; Pei Z; Shang HF; Shi CH; Song K; Tan AH; Wu YR; Xu YM; Xu R; Yan Y; Yang J; Zhang B; Koh WP; Lim SY; Khor CC; Liu J; Tan EK
    JAMA Neurol; 2020 Jun; 77(6):746-754. PubMed ID: 32310270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide determinants of mortality and motor progression in Parkinson's disease.
    Tan MMX; Lawton MA; Pollard MI; Brown E; Real R; Carrasco AM; Bekadar S; Jabbari E; Reynolds RH; Iwaki H; Blauwendraat C; Kanavou S; Hubbard L; Malek N; Grosset KA; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Wood NW; Williams-Gray CH; Andreassen OA; Toft M; Elbaz A; Artaud F; Brice A; Corvol JC; Aasly J; Farrer MJ; Nalls MA; Singleton AB; Williams NM; Ben-Shlomo Y; Hardy J; Hu MTM; Grosset DG; Shoai M; Pihlstrøm L; Morris HR
    NPJ Parkinsons Dis; 2024 Jun; 10(1):113. PubMed ID: 38849413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI).
    Nalls MA; Keller MF; Hernandez DG; Chen L; Stone DJ; Singleton AB;
    Mov Disord; 2016 Jan; 31(1):79-85. PubMed ID: 26268663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal Epigenome-Wide Methylation Study of Cognitive Decline and Motor Progression in Parkinson's Disease.
    Chuang YH; Lu AT; Paul KC; Folle AD; Bronstein JM; Bordelon Y; Horvath S; Ritz B
    J Parkinsons Dis; 2019; 9(2):389-400. PubMed ID: 30958317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of Apolipoprotein ε4 Genotypes with Motor and Nonmotor Symptoms in Parkinson's Disease: A Cross-Sectional Study.
    Kapan A; Haider S; Wakolbinger M; Spatt J
    Mov Disord Clin Pract; 2023 Nov; 10(11):1611-1619. PubMed ID: 38026513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mendelian Randomisation Finds No Causal Association between Urate and Parkinson's Disease Progression.
    Coneys R; Storm CS; Kia DA; Almramhi M; Wood NW
    Mov Disord; 2021 Sep; 36(9):2182-2187. PubMed ID: 34056740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.
    Posavi M; Diaz-Ortiz M; Liu B; Swanson CR; Skrinak RT; Hernandez-Con P; Amado DA; Fullard M; Rick J; Siderowf A; Weintraub D; McCluskey L; Trojanowski JQ; Dewey RB; Huang X; Chen-Plotkin AS
    PLoS Med; 2019 Oct; 16(10):e1002931. PubMed ID: 31603904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal Changes in Parkinson's Disease Symptoms with and Without Rapid Eye Movement Sleep Behavior Disorder: The Oxford Discovery Cohort Study.
    Liu Y; Lawton MA; Lo C; Bowring F; Klein JC; Querejeta-Coma A; Scotton S; Welch J; Razzaque J; Barber T; Ben-Shlomo Y; Hu MT
    Mov Disord; 2021 Dec; 36(12):2821-2832. PubMed ID: 34448251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replication of a Novel Parkinson's Locus in a European Ancestry Population.
    Grover S; Kumar-Sreelatha AA; Bobbili DR; May P; Domenighetti C; Sugier PE; Schulte C; ; Elbaz A; Krüger R; Gasser T; Sharma M;
    Mov Disord; 2021 Jul; 36(7):1689-1695. PubMed ID: 33760272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
    Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
    BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.